Heliyon (Jul 2023)

Can the salivary urea and stimulated saliva concentration be a marker of periodontal diseases in opioid users? A case-control study

  • Parvin parvaei,
  • Marzie eydzadeh,
  • Freshteh Osmani

Journal volume & issue
Vol. 9, no. 7
p. e17093

Abstract

Read online

Introduction: & Aim: Microbial plaque is the primary cause of periodontal diseases, and smoking and opioid addiction can accelerate microbial plaque formation and disease progression. Adequate saliva flow and salivary urea concentration are important parameters for a healthy periodontium. In this study, the relationship between Periodontal Diseases and the History of opioid addiction was investigated by measuring the Salivary Urea and Stimulated Saliva Concentration. Materials & methods: This case-control study was conducted on 240 patients (120 cases and 120 controls) in 2021 referred to addiction treatment centers and the dental clinic in Iran, Birjand. The control and case groups were matched in terms of age. Demographic, base data, and clinical examination results were collected by a checklist. Data were analyzed using SPSS 19 and one-way ANOVA and chi-square tests. P-value 0.05). Conclusion: Following the use of opioids, the flow of saliva decreases, and with the exacerbation of the periodontal disease, the concentration of urea in saliva increases. Therefore, it seems that the analysis of saliva parameters, including urea concentration, can be useful for the diagnosis of periodontal disease, and saliva urea concentration is not directly related to opioid use.

Keywords